Investment Analysis
Goldman Weighs Sweeter Terms on Loan Tied to DuPont Unit Sale
Goldman Sachs Group Inc. is considering sweetening the terms on $1.73 billion of leveraged loans tied to chemical maker Arclin Inc.’s acquisition of DuPont de Nemours Inc.’s Aramids business.
Goldman Sachs Group Inc. is considering sweetening the terms on $1.73 billion of leveraged loans tied to chemical maker Arclin Inc.’s acquisition of DuPont de Nemours Inc.’s Aramids business.
Topics: DuPontArclinAramidsLoan